Israeli startup to use AI to transform antibody discovery, design

"The launch of CombinAble heralds a shift in the approach to targeted antibody design by leveraging AI to optimize and expedite the discovery process," said Mati Gill, CEO of AION Labs.

  News   Mar 17, 2024   0   37  Add to Reading List
Israeli startup to use AI to transform antibody discovery, design

"The launch of CombinAble heralds a shift in the approach to targeted antibody design by leveraging AI to optimize and expedite the discovery process," said Mati Gill, CEO of AION Labs.
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow